Management of drug-resistant tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of drug-resistant tuberculosis

Published:2019-09 Issue:10202 Volume:394 Page:953-966
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lange Christoph,Dheda Keertan,Chesov Dumitru,Mandalakas Anna Maria,Udwadia Zarir,Horsburgh C Robert

Funder

South African Medical Research Council

The European and Developing Countries Clinical Trials Partnership

Publisher

Elsevier BV

Subject

General Medicine

Reference90 articles.

1. Global tuberculosis report 2018,2018

2. Revising the definition of extensively drug-resistant tuberculosis;Lange;Lancet Respir Med,2018

3. A trial of a shorter regimen for rifampin-resistant tuberculosis;Nunn;N Engl J Med,2019

4. Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial;von Groote-Bidlingmaier;Lancet Respir Med,2019

5. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement;Dominguez;Int J Tuberc Lung Dis,2016

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tuberculosis effect of microbiome therapeutic PMC205 in extensively drug-resistant pulmonary tuberculosis in vivo;International Journal of Antimicrobial Agents;2024-09

2. Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatment;Respiratory Medicine;2024-09

3. Surveillance for TB drug resistance using routine rapid diagnostic testing data: Methodological development and application in Brazil;2024-07-23

4. Clinical effects of detailed nursing management interventions on medication adherence and disease perception in patients with drug-resistant tuberculosis;World Journal of Clinical Cases;2024-07-16

5. Mycobacterium gordoniasis of the cervical lymph nodes: A case report;World Journal of Clinical Cases;2024-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3